4.4 Article

High-density substrate-guided ventricular tachycardia ablation: Role of activation mapping in an attempt to improve procedural effectiveness

期刊

HEART RHYTHM
卷 10, 期 12, 页码 1850-1858

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.hrthm.2013.09.059

关键词

Catheter ablation; Ventricular tachycardia; Ischemic heart disease; Nonischemic cardiomyopathy; Electroanatomical mapping

资金

  1. St Jude Medical
  2. Biosense Webster
  3. Boston Scientific

向作者/读者索取更多资源

BACKGROUND Advanced techniques of electroanatomical mapping efficiently guide ventricular tachycardia (VT) ablation strategies; in this context, the adjunctive value of combining activation mapping (AMap) to improve accuracy has not been elucidated. OBJECTIVE To investigate whether conventional AMap further contributes to the identification of critical sites of VT reentry and whether this translates into a more effective ablation outcome in a cohort of patients undergoing VT ablation. METHODS We prospectively enrolled 126 patients (mean age 65.3 +/- 10.5 years; left ventricular ejection fraction 33.3% +/- 7.2%) with ischemic (n = 89) or idiopathic (n = 37) dilated cardiomyopathy undergoing endocardial (n = 105) or endo-epicardiaL (n = 21) electroanatomical mapping and ablation. A substrate-guided strategy targeting surrogate markers of reentry was accomplished in all patients, but the feasibility and efficacy of AMap was preliminarily assessed for all induced VTs focusing on early VT suppression obtained during radiofrequency delivery. VT-free survival was assessed by ICD interrogation. RESULTS AMap successfully guided ablation in 62 of 104 (59.6%) patients with inducible VT(s). At 1 year, 6 of 126 (4.8%) patients died; VT recurred in 28 of 126 (22.2%) patients. No significant difference in VT recurrence rate was observed between patients in whom AMap proved effective versus those in whom substrateguided ablation was not corroborated by AMap (16 of 62 [25.8%] vs 12 of 64 [18.8 /d; Log-rank test, P = .3). CONCLUSIONS Our findings support the efficacy of a substrateguided strategy targeting specific markers of arrhythmogenicity identified during sinus rhythm. AMap proves highly efficient acutely but does not improve overall VT-free survival, suggesting that in patients with advanced cardiac disease, Life-threatening arrhythmias can be successfully treated by ablation in sinus rhythm, thus Limiting procedural risks.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据